Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03221738 · ClinicalTrials.gov registry record · NA
Smartphone-Administered App Treatment for Adults With Body Dysmorphic Disorder
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT03221738: Completed NA study, sponsored by Massachusetts General Hospital.
NCT03221738 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03221738, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The investigators are developing and testing a Smartphone-based cognitive behavioral therapy (CBT) "app" for body dysmorphic disorder (BDD). The investigators hypothesize that app-based CBT for BDD will be feasible and acceptable to individuals with BDD, and will improve body image concerns and related outcomes.
Interventions
- BEHAVIORAL App-Based Cognitive Behavioral Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2017-07-24 |
| Est. Completion | 2019-01-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03221738
The ClinicalTrials.gov registry entry for NCT03221738 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which App-Based Cognitive Behavioral Therapy is the first listed.
NCT03221738 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03221738 about?
NCT03221738 is a clinical study titled "Smartphone-Administered App Treatment for Adults With Body Dysmorphic Disorder". The investigators are developing and testing a Smartphone-based cognitive behavioral therapy (CBT) "app" for body dysmorphic disorder (BDD). The investigators hypothesize that app-based CBT for BDD will be feasible and acceptable to individuals with BDD, and will improve body image concerns and rela...
What is the current status of trial NCT03221738?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2017-07-24. Estimated completion is 2019-01-18.
What interventions are being tested in trial NCT03221738?
The interventions under investigation include: App-Based Cognitive Behavioral Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT03221738?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.